To view the PDF file, sign up for a MySharenet subscription.

OLD MUTUAL PLC - Form 8.3 - Public Opening Position Disclosure Quantum Pharma Plc

Release Date: 21/09/2017 14:50
Code(s): OML     PDF:  
Wrap Text
Form 8.3 - Public Opening Position Disclosure – Quantum Pharma Plc

OLD MUTUAL PLC
ISIN CODE: GB00B77J0862
JSE SHARE CODE: OML
NSX SHARE CODE: OLM
ISSUER CODE: OLOMOL
Old Mutual
                                                                                            FORM 8.3

          PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
      A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
                                         MORE
                      Rule 8.3 of the Takeover Code (the “Code”)

1.       KEY INFORMATION

 (a) Full name of discloser:                                               Old Mutual plc 
                                                                          (and subsidiaries)
 (b) Owner or controller of interests and short
     positions disclosed, if different from 1(a):
     The naming of nominee or vehicle companies is
     insufficient. For a trust, the trustee(s), settlor and
     beneficiaries must be named.
 (c) Name of offeror/offeree in relation to whose                        Quantum Pharma Plc 
     relevant securities this form relates:
     Use a separate form for each offeror/offeree
 (d) If an exempt fund manager connected with an               
     offeror/offeree, state this and specify identity
     of offeror/offeree:
 (e) Date position held/dealing undertaken:                                  20/09/2017 
     For an opening position disclosure, state the latest
     practicable date prior to the disclosure
 (f) In addition to the company in 1(c) above, is the                     Clinigen Group Plc 
     discloser making disclosures in respect of any
     other party to the offer?
     If it is a cash offer or possible cash offer, state
     “N/A”

2.       POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant
securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.

(a)      Interests and short positions in the relevant securities of the offeror or offeree
         to which the disclosure relates following the dealing (if any)

 Class of relevant security:                                      10p Ordinary

                                                Interests                        Short positions
                                             Number                 %            Number          %
 (1) Relevant securities owned               440,328              0.26%
     and/or controlled:
 (2) Cash-settled derivatives:                                       

 (3) Stock-settled derivatives                                       
     (including options) and
                                                                                                    

       agreements to
       purchase/sell:
                                       440,328         0.26%
    TOTAL:
Please note we do not have voting rights within 120,561 of the above total holdings.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements
to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open
Positions).

(b)        Rights to subscribe for new securities (including directors’ and other employee
           options)

 Class of relevant security in relation to
 which subscription right exists:
 Details, including nature of the rights
 concerned and relevant percentages:


3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class
of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

      Class of relevant       Purchase/sale               Number of            Price per unit
          security                                        securities
          Ordinary               Purchase                  10,299                  0.77 GBP


(b)        Cash-settled derivative transactions

       Class of          Product              Nature of dealing      Number of        Price per
       relevant         description        e.g. opening/closing a    reference           unit
       security          e.g. CFD            long/short position,    securities
                                           increasing/reducing a
                                              long/short position




(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

  Class        Product        Writing,        Number      Exercis     Type        Expir   Option
    of        descriptio     purchasin            of      e price      e.g.         y     money
 relevan      n e.g. call    g, selling,      securitie   per unit   America      date     paid/
     t          option        varying            s to                   n,                receive
 securit                         etc.          which                 Europea               d per
    y                                          option                 n etc.                unit
                                               relates
                                                                                               


(ii)     Exercise

       Class of          Product         Exercising/       Number of          Exercise price
       relevant        description        exercised        securities            per unit
       security       e.g. call option     against



(d)      Other dealings (including subscribing for new securities)

  Class of relevant         Nature of dealing             Details         Price per unit (if
      security              e.g. subscription,                              applicable)
                               conversion




4.       OTHER INFORMATION

(a)      Indemnity and other dealing arrangements

 Details of any indemnity or option arrangement, or any agreement or understanding,
 formal or informal, relating to relevant securities which may be an inducement to
 deal or refrain from dealing entered into by the person making the disclosure and
 any party to the offer or any person acting in concert with a party to the offer:
 Irrevocable commitments and letters of intent should not be included. If there are no such
 agreements, arrangements or understandings, state “none”


 None 

(b)      Agreements, arrangements or understandings relating to options or derivatives

 Details of any agreement, arrangement or understanding, formal or informal,
 between the person making the disclosure and any other person relating to:
 (i) the voting rights of any relevant securities under any option; or
 (ii) the voting rights or future acquisition or disposal of any relevant securities to
      which any derivative is referenced:
 If there are no such agreements, arrangements or understandings, state “none”

(c)      Attachments

 Is a Supplemental Form 8 (Open Positions) attached?                               No




 Date of disclosure:                                        21 September 2017      

 Contact name:                                                  Rose Coyle 

 Telephone number:                                            0207 002 7503 


Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service
and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s
Market Surveillance Unit is available for consultation in relation to the Code’s disclosure
requirements on +44 (0)20 7638 0129.
                                                                                

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Sponsor:
Merrill Lynch South Africa (Pty) Ltd

Joint Sponsor:
Nedbank Corporate and Investment Banking

Date: 21/09/2017 02:50:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story